Hydroxyamine

Hydroxyamine

SCHEMBL11026958

NO.O=C(OC(C(=O)O)(C(=O)c1ccccc1)C(O)C(=O)O)c1ccccc1

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 3/20 0.41
▸ TP53 P04637 1/20 0.41
▸ ALDH1A1 P00352 4/20 0.39
▸ F2 P00734 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ CES1 P23141 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ MAPT P10636 2/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ HIF1A Q16665 1/20 0.37
▸ POLB P06746 1/20 0.37
▸ TDP1 Q9NUW8 4/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ CYP1A2 P05177 1/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ SRC P12931 1/20 0.35
▸ ADRB2 P07550 2/20 0.35
▸ ADRB1 P08588 2/20 0.35
▸ ADRB3 P13945 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1483657 0.97 TSHR (0.43) TSHRTP53ALDH1A1F2LMNA
SCHEMBL223031 0.97 TSHR (0.43) TSHRTP53ALDH1A1F2LMNA
SCHEMBL27362899 0.97 TSHR (0.43) TSHRTP53ALDH1A1F2LMNA
SCHEMBL221679 0.97 TSHR (0.43) TSHRTP53ALDH1A1F2LMNA
SCHEMBL2904556 0.97 TSHR (0.43) TSHRTP53ALDH1A1F2LMNA
SCHEMBL7686 0.97 TSHR (0.43) TSHRTP53ALDH1A1F2LMNA
Ammonia Solution, Strong SCHEMBL11444698 0.95 TSHR (0.42) TSHRTP53ALDH1A1F2LMNA
Water SCHEMBL1818831 0.95 TSHR (0.42) TSHRTP53ALDH1A1F2LMNA
SCHEMBL3946464 0.95 TSHR (0.42) TSHRTP53ALDH1A1F2LMNA
SCHEMBL11542849 0.95 TSHR (0.42) TSHRTP53ALDH1A1F2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106632401-A Methods and compounds for the synthesis of fused aminodihydrothiazine derivatives 卫材R&D管理有限公司 2017-05-10 — — CN disclosed
EP-2665716-B1 METHODS AND COMPOUNDS USEFUL IN THE SYNTHESIS OF FUSED AMINODIHYDROTHIAZINE DERIVATIVES EISAI R&D MAN CO LTD (JP) 2017-03-08 — — EP disclosed
US-8962858-B2 Methods and compounds useful in the synthesis of fused aminodihydrothiazine derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2015-02-24 — — US disclosed
US-20140309429-A1 METHODS AND COMPOUNDS USEFUL IN THE SYNTHESIS OF FUSED AMINODIHYDROTHIAZINE DERIVATIVES EISAI R&D MAN CO LTD (JP) 2014-10-16 — — US disclosed
US-8802871-B2 Methods and compounds useful in the synthesis of fused aminodihydrothiazine derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2014-08-12 — — US disclosed
CN-103502231-A Methods and compounds for the synthesis of fused aminodihydrothiazine derivatives EISAI R&D MAN CO LTD 2014-01-08 — — CN disclosed
EP-2665716-A1 METHODS AND COMPOUNDS USEFUL IN THE SYNTHESIS OF FUSED AMINODIHYDROTHIAZINE DERIVATIVES Eisai R&D Management Co., Ltd. (JP) 2013-11-27 — — EP disclosed
US-20130197244-A1 METHODS AND COMPOUNDS USEFUL IN THE SYNTHESIS OF FUSED AMINODIHYDROTHIAZINE DERIVATIVES EISAI R&D MANAGEMENT CO., LTD. (JP) 2013-08-01 — — US disclosed
US-8426584-B2 Methods and compounds useful in the synthesis of fused aminodihydrothiazine derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2013-04-23 — — US disclosed
US-20120190848-A1 METHODS AND COMPOUNDS USEFUL IN THE SYNTHESIS OF FUSED AMINODIHYDROTHIAZINE DERIVATIVES EISAI R&D MANAGEMENT CO., LTD. (JP) 2012-07-26 — — US disclosed
WO-2012100179-A1 METHODS AND COMPOUNDS USEFUL IN THE SYNTHESIS OF FUSED AMINODIHYDROTHIAZINE DERIVATIVES EISAI R&D MANAGEMENT CO., LTD. (JP) 2012-07-26 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140309429-A1 METHODS AND COMPOUNDS USEFUL IN THE SYNTHESIS OF FUSED AMINODIHYDROTHIAZINE DERIVATIVES APP, BACE1, BACE2 TSHR 4545/4885TP53 877/4885ALDH1A1 3129/4885
US-20130197244-A1 METHODS AND COMPOUNDS USEFUL IN THE SYNTHESIS OF FUSED AMINODIHYDROTHIAZINE DERIVATIVES APP, BACE1, BACE2 TSHR 4545/4885TP53 877/4885ALDH1A1 3129/4885
US-20120190848-A1 METHODS AND COMPOUNDS USEFUL IN THE SYNTHESIS OF FUSED AMINODIHYDROTHIAZINE DERIVATIVES APP, BACE1, BACE2 TSHR 4545/4885TP53 877/4885ALDH1A1 3129/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback